
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- MSDS Documents
- Personal Protection
| - Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Regulatory/Standards/Labels
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
| Example of Acute Exposure data from MEDITEXT. |
All Other Data Sources:
CHRIS Documents
DART Documents
•
[Experience of usage Magne-B6 in obstetritian practice]
•
[Study on macroelements in fetal organic tissues and mother serum]
•
[The effect of fluoride-arsenic exposure on the macroelements in serum of rats' offspring]
More...
•
A population-based case-control teratological study of furosemide treatment during pregnancy.
•
Alterations in development resulting from nutrient imbalance.
•
An inverse correlation between umbilical cord blood ionized magnesium (IMG) and interleukin-6 (IL-6) levels could not be confirmed in the human.
•
Analysis of the drinking water of mothers of neural tube defect infants and of normal infants for 14 selected trace elements by Inductively Coupled Plasma-Mass Spectrometry (ICP-MS).
•
Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP).
•
Calcium and magnesium in pregnancy.
•
Can maternal magnesium (Mg) and nifedipine (NIF) therapy inhibit umbilical vessel contractility and exacerbate bleeding in the neonate?
•
Combined Mg2+ and Ca2+ deficiency during fetal and postnatal life increases levels of the 28 kDa calcium-binding protein (calbindin) in brain.
•
Comparative effects of a carcinogenic (As) and an anticancer (Ga) metal on the transfer through the human amnion: relationship with Mg; ultrastructural and electrophysiological studies.
•
Developmental effects and tissue trace elements in rats fed excess dietary calcium.
•
Do High Magnesium Exposures In Preterm Labor Render Antenatal Betamethasone Less Effective As Prophylaxis For Neonatal Ivh?
•
Effect of intravenous magnesium sulfate on the biophysical profile of the preterm fetus.
•
Effect of magnesium administration on oxygen free radical generation during in-utero hypoxia in the fetal guinea pig brain.
•
Effect of maternal diabetes mellitus on magnesium transport across the rat placenta.
•
Effect of maternal magnesium sulfate (MgSO4) therapy on neonatal outcome.
•
Effect of maternally administered magnesium sulfate on the neonate.
•
Effect of prenatal ethanol exposure on hippocampal NMDA receptors and magnesium regulation of NMDA receptor function in rat offspring.
•
Effects of antenatal magnesium exposure on neonatal mortality and morbidity.
•
Effects of maternal magnesium sulfate on preterm newborns.
•
Effects of resonant magnetic fields on chick femoral development in vitro.
•
Evaluation Of Some Inhibitor And Activator Factors In Sperm Motility In Brycon henni.
•
High-dose intravenous use of magnesium in pregnancy.
•
Human placental magnesium and the contamination with cadmium and lead of placenta.
•
Impaired clearance of serum magnesium in the very low birth weight (VLBW, less than 1500 g) neonate as compared to its mother.
•
In utero magnesium exposure: effects on ELBW infants at 18 months adjusted age.
•
Issues of human exposure to agents causing developmental toxicity.
•
Magnesium induces apoptosis in first trimester, preterm and term human placenta.
•
Magnesium-induced hypocalcemia in salicylate-treated pregnant rats.
•
Maternal and cord electrolytes in alcohol abusing and abstaining gravidas.
•
Maternal hair zinc, copper and magnesium concentration in neural tube defects in Turkey.
•
Maternal iron, Copper, Magnesium and Calcium Levels in Preterm Delivery and the Effect of These Trace Elements on Birth Weight.
•
Maternal serum magnesium in non diabetic and diabetic women: association with spontaneous abortion.
•
Maternal trace elements and fetal congenital malformations.
•
Maternal trace elements, vitamin B12, viatmin A, folic acid and fetal malformations.
•
Maternal trace elements, vitamin B12, vitamin A, folic acid and fetal malformations.
•
Maternal trace elements, vitamin B12, vitamin A, folic acid and fetal malformations.
•
Maternal trace elements, vitamine B12, vitamine A, folic acid and fetal malformations.
•
Maternal-fetal transfer of magnesium across the human placenta.
•
Micronutrients and pregnancy outcome: a review of the literature.
•
Neuroprotective effect of antepartum magnesium on NMDA receptor of fetal guinea pig brain during hypoxia.
•
Nutrition in maternity.
•
Perinatal hypoxia and magnesium: I -- functional study.
•
Perinatal hypoxia and magnesium: II -- histochemical study.
•
Prenatal ethanol exposure enhances Mg++ regulation of depolarizing responses to NMDA in rat hippocampal CA1 pyramidal cells.
•
Prolonged magnesium therapy affects fetal bone.
•
Relationship of maternal trace element nutriture with pregnancy outcome in Kuwait.
•
Relative hypoparathyroidism in pregnant drug abusers and their newborn at the time of delivery.
•
Spatial and temporal trends of contaminants in eggs of wading birds from San Francisco Bay, California.
•
The clinical effects of maternally administered magnesium sulfate on the neonate.
•
The effect of in utero hypoxia on fetal heart and brain trace metals.
•
The effect of magnesium on matrix metalloproteinase-9 activity in umbilical cord blood at delivery of pregnancies complicated by chorioamnionitis.
•
The effect of magnesium sulfate on fetal rat brain and body physical characteristics.
•
The effects of maternal training on plasma copper, magnesium and zinc in rats.
•
Toxicity and teratogenicity of some metals in chick embryos.
•
Trace element (zinc, copper, iron and magnesium) concentrations in human placenta and their relationship to birth weight of babies.
•
Utilization of an in vitro embryo culture model to investigate magnesium (Mg) deficiency-induced teratogenesis.
ECOTOX Documents
ERG2016 Guidebook
Fisher MSDS
HSDB® Data Bank
LOLI® Listings
New Jersey Fact Sheets
OHM/TADS Documents
REPROTOX® Documents
RTECS® Registry
MSDSonline®
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations

CFR Regulations

Example Content from MEDITEXT for 7439-95-4:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Magnesium is available in many forms and has many different medical uses, including as an antacid and laxative, anticonvulsant, treatment of torsades de pointes, pre-eclampsia, management of acute asthma exacerbation, hydrofluoric acid ingestion, enema, and electrolyte supplement. Magnesium is an essential electrolyte in the body and is a cofactor in many enzyme systems. Industrially, magnesium is used as a component of aluminum alloys, in die-casting alloyed with zinc, to remove sulfur in the production of iron and steel, and for the production of titanium.
- PHARMACOLOGY: When taken orally, magnesium promotes bowel evacuation by osmotic retention of fluid which distends the colon and increases peristaltic activity. Parenteral magnesium decreases acetylcholine in motor nerve terminals and acts on myocardium by slowing rate of S-A node impulse formation and prolonging conduction time as well as stabilizing excitable membranes. Magnesium is also necessary for the movement of other electrolytes (calcium, sodium and potassium) in and out of cell.
- TOXICOLOGY: In overdose, magnesium impairs neuromuscular transmission, manifested as weakness and hyporeflexia.
- EPIDEMIOLOGY: Thousands of exposures occur every year, but severe manifestations are very rare. Severe toxicity is most common after intravenous infusion over multiple hours (usually for pre-eclampsia), and can occur after chronic excessive doses, especially in the setting of renal insufficiency. Severe toxicity has been reported after acute ingestion but is very rare.
- WITH THERAPEUTIC USE
- Adverse effects seen with magnesium sulfate include adverse effects on neuromuscular function and flushing (IV, dose-related), hypotension (IV, rate-related), and vasodilation (IV, rare-related). Magnesium sulfate may also cause diarrhea. Magnesium hydroxide has many drug interactions secondary to its antacid effect.
- WITH POISONING/EXPOSURE
- MILD TO MODERATE TOXICITY: Nausea and vomiting are common with oral exposure. Flushing can occur most often with intravenous administration. Magnesium dust can irritate the eye and mucous membranes of the upper respiratory tract causing an atrophic nasopharyngitis. Metal fume fever can result from inhalation of magnesium fumes.
- SEVERE TOXICITY: Severe toxicity occurs most often after intravenous infusions. It can also occur after chronic excessive oral doses, often in patients with renal insufficiency. Early manifestations are lethargy, hyporeflexia, followed by weakness, paralysis, hypotension, ECG changes (prolonged PR and QRS intervals), CNS depression, seizures, and respiratory depression.
© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.